News By Tag
News By Place
Wareham Development announces fourth new lease at EmeryStation West
By: Wareham Development
Catalent, an international drug development and manufacturing company with an existing Bay Area presence, will take half of the 4th floor with an anticipated move-in late 1Q 2019.
"Catalent Biologics has been looking for the best place to grow in the Bay Area, and we decided that the cluster at EmeryStation and its beautiful new EmeryStation West building were ideal for us," says Michael Riley, Vice President, General Manager, Drug Substance & Biologics Analytical Services of Catalent Biologics.
"Catalent's presence in the Bay Area is an important one. We are delighted that they will advance their strategy for the region at EmeryStation,"
Catalent is an international drug development, delivery and supply partner for drugs, biologics and consumer health products. Catalent announced its initial public offering and became publicly traded on the New York Stock Exchange under the ticker symbol CTLT in 2014.
Catalent Biologics' current Bay Area location features development and production for the company's proprietary SMARTag® Technology. SMARTag® Technology is a precision protein-chemical engineering technology for the development of advanced antibody-drug conjugates (ADCs).
Wareham Development was represented by the Kidder Mathews team of Timothy Mason, James Bennett and Eric Bluestein. Catalent was represented by the Cushman & Wakefield team of Jon Gorczyca and Marc Ward.
The world class addition to Wareham's highly-successful 2-million SF EmeryStation research and tech campus was designed to meet LEED Gold standards. Its seven levels of laboratory and office space sit above a two-story transit center and 125-car parking podium.
The construction team, led by Perkins + Will, one of the preeminent firms specializing in the design of laboratories and office for the life science and tech sectors, included Nova Partners, DPR Construction, Rutherford + Chekene, and Interface Engineering.
The new East Bay/Transbay transit center at the street level will serve Amtrak's Capitol Corridor commuter route from Sacramento to San Jose. Bus bays allow passengers to hop off the train and access last-mile transit options including AC Transit to the new San Francisco Transbay facility or elsewhere, to the free EmeryGoRound shuttle to BART and around Emeryville, or to taxis, limos, car and bike shares.
In its 40th year, Wareham Development is one of the largest privately-held real estate development and property management companies in the Bay Area. It has been in the forefront of the transformation of Emeryville and Berkeley into an international hub of headquarters for the research and tech sectors, most of whom reside in its EmeryStation and its Aquatic Park Center research and tech campuses.
Wareham's mixed-use, multi-tenanted research and tech campuses in Emeryville, Berkeley, Richmond, and Palo Alto award-winning architecture, spectacular landscaping, abundant tenant-friendly amenities, and superb property management—all hallmarks of Wareham projects.
Wareham tenants encompass the spark and promise of small companies on the verge of growth, and large corporations whose fortunes span the globe.
"We are proud of our associations with all of our tenants and feel deeply privileged to play a role in their success," says Sears.
Wareham Development has helped to shape the Bay Area since 1977 with a real estate portfolio encompassing more than 4.5 million square feet of space located in multi-tenant, mixed-use campuses with award-winning architecture, spectacular landscaping, and tenant-friendly amenities. They are committed to the long-term economic and environmental vitality of the communities where they do business, and are dedicated to supporting neighboring school districts and students. www.warehamdevelopment.com